CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 92 enrolled
Drug / intervention
Balafilcon A contact lens +4 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01629706
NCT01629706N/ACompleted
CompareCT.gov

Determination of Cell Population in SICS and Symptomatic Versus Asymptomatic Lens Wearers

CIBA VISION·interventional·Posted Jun 28, 2012·Updated Mar 3, 2015

In Brief

A clinical study evaluating Balafilcon A contact lens, Habitual contact lenses, and 3 other interventions for Refractive Error and Dry Eye. Completed, enrolled 92 participants.

Detailed Summary

The purpose of the study is to investigate the corneal epithelial cell response associated with lens wear that results in solution-induced corneal staining (Phase1) and to determine the cell appearance in symptomatic and asymptomatic contact lens wearers (Phase 2).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Error, Dry Eye
Countries--
CollaboratorsUniversity of Waterloo

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 28, 2012
Enrollment StartSep 1, 2012
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.0 years ago

Interventions

Balafilcon A contact lensdevice

Commercially marketed silicone hydrogel contact lens

Habitual contact lensesdevice

Commercially marketed silicone hydrogel contact lenses as prescribed by eye care practitioner, brand and power

Renu multi-purpose solutiondevice

Commercially marketed solution for use in removing protein, cleaning, conditioning, and disinfecting contact lenses.

ClearCaredevice

Commercially marketed hydrogen peroxide system for cleaning and disinfecting contact lenses

Habitual lens caredevice

Lens care per habitual use